Michael May

772 total citations
38 papers, 502 citations indexed

About

Michael May is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Michael May has authored 38 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Michael May's work include Pancreatic and Hepatic Oncology Research (11 papers), Cancer Genomics and Diagnostics (9 papers) and Renal cell carcinoma treatment (4 papers). Michael May is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Cancer Genomics and Diagnostics (9 papers) and Renal cell carcinoma treatment (4 papers). Michael May collaborates with scholars based in United States, South Africa and Japan. Michael May's co-authors include Julian A. Abrams, Ravi Vijayvargia, Joseph D. Fondell, Anne‐Catrin Uhlemann, Christine J. Kubin, Jason Zucker, Magdalena E. Sobieszczyk, Donald Dietz, Connor J. Kinslow and Simon K. Cheng and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Michael May

32 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael May United States 12 151 131 123 114 99 38 502
Anthony J. Perissinotti United States 14 175 1.2× 116 0.9× 97 0.8× 58 0.5× 64 0.6× 67 606
Mariona Calvo Spain 7 179 1.2× 74 0.6× 77 0.6× 34 0.3× 52 0.5× 20 344
Lihua Xing China 13 31 0.2× 293 2.2× 200 1.6× 43 0.4× 109 1.1× 35 676
Marie Simon France 10 114 0.8× 124 0.9× 235 1.9× 109 1.0× 68 0.7× 20 569
Christophe Bazin France 14 82 0.5× 26 0.2× 172 1.4× 166 1.5× 77 0.8× 35 593
Fukashi Yamamichi Japan 16 38 0.3× 94 0.7× 155 1.3× 93 0.8× 192 1.9× 52 525
K. Ramachandran India 14 75 0.5× 90 0.7× 71 0.6× 136 1.2× 75 0.8× 70 550
Canan Vergin Türkiye 13 46 0.3× 109 0.8× 104 0.8× 27 0.2× 26 0.3× 47 400
Michele W. Sugrue United States 14 135 0.9× 46 0.4× 154 1.3× 79 0.7× 103 1.0× 27 668
Jennifer Drahos United States 13 65 0.4× 124 0.9× 147 1.2× 289 2.5× 185 1.9× 31 699

Countries citing papers authored by Michael May

Since Specialization
Citations

This map shows the geographic impact of Michael May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael May more than expected).

Fields of papers citing papers by Michael May

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael May. The network helps show where Michael May may publish in the future.

Co-authorship network of co-authors of Michael May

This figure shows the co-authorship network connecting the top 25 collaborators of Michael May. A scholar is included among the top collaborators of Michael May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael May. Michael May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
May, Michael, Jonathan Lee, Xin Ma, et al.. (2025). The impact of eligibility criteria on Kirsten rat sarcoma G12C inhibitor trials in patients with non–small cell lung cancer. JNCI Journal of the National Cancer Institute. 118(1). 49–57.
2.
May, Michael. (2025). Cell Division, Life, and Cancer: Novel Fundamental Insights. Critical Reviews in Eukaryotic Gene Expression. 35(5). 33–38.
3.
May, Michael, Alexander G. Raufi, Lyndon Luk, et al.. (2024). A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX. The Oncologist. 29(4). 350–355. 1 indexed citations
4.
5.
May, Michael, Heekuk Park, Sun Da-jiang, et al.. (2024). Low Bacterial Biomass in Human Pancreatic Cancer and Adjacent Normal Tissue. International Journal of Molecular Sciences. 26(1). 140–140. 2 indexed citations
6.
7.
Qunaj, Lindor, et al.. (2023). Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer. Frontiers in Oncology. 13. 1252516–1252516. 17 indexed citations
8.
May, Michael, et al.. (2023). Smoking is Not Associated with Lung Metastasis in Pancreatic Cancer. Cancer Investigation. 41(5). 487–490. 2 indexed citations
9.
May, Michael, Elvira Singh, Wenlong Carl Chen, et al.. (2023). Biochemical progression free and overall survival among Black men with stage IV prostate cancer in South Africa: Results from a prospective cohort study. Cancer Medicine. 13(1). e6739–e6739. 2 indexed citations
10.
Migliori, Edoardo, Jianing Fu, Amer Assal, et al.. (2023). The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. Frontiers in Immunology. 14. 1212203–1212203. 5 indexed citations
11.
Raufi, Alexander G., et al.. (2023). Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer. International Journal of Molecular Sciences. 24(4). 4238–4238. 28 indexed citations
12.
May, Michael, Michelle Chang, Donald Dietz, et al.. (2021). Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019. Antimicrobial Agents and Chemotherapy. 65(4). 36 indexed citations
13.
Kubin, Christine J., Thomas H. McConville, Donald Dietz, et al.. (2021). Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections. Open Forum Infectious Diseases. 8(6). ofab201–ofab201. 103 indexed citations
14.
May, Michael, Connor J. Kinslow, Christopher Adams, et al.. (2021). Outcomes for localized treatment of large cell neuroendocrine carcinoma of the lung in the United States. Translational Lung Cancer Research. 10(1). 71–79. 15 indexed citations
15.
May, Michael, Alexander G. Raufi, Karen Chen, et al.. (2021). Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the Literature. The Oncologist. 26(8). 640–646. 7 indexed citations
16.
Kinslow, Connor J., Michael May, Margaret M. Kozak, Erqi L. Pollom, & Daniel T. Chang. (2020). Signet ring cell carcinoma of the Ampulla of Vater: outcomes of patients in the United States. HPB. 22(12). 1759–1765. 8 indexed citations
17.
Wong, Winston, Michael May, Susan Whittier, et al.. (2020). A double-edged sword: Prolonged detection of SARS-COV-2 in patients receiving cancer directed therapy. Seminars in Oncology. 48(2). 166–170. 1 indexed citations
18.
May, Michael, et al.. (2018). Comparing preoperative imaging modalities in patient selection for breast intraoperative radiotherapy. Journal of Surgical Oncology. 118(6). 959–965. 4 indexed citations
19.
May, Michael & Julian A. Abrams. (2018). Emerging Insights into the Esophageal Microbiome. Current Treatment Options in Gastroenterology. 16(1). 72–85. 52 indexed citations
20.
Vijayvargia, Ravi, Michael May, & Joseph D. Fondell. (2007). A Coregulatory Role for the Mediator Complex in Prostate Cancer Cell Proliferation and Gene Expression. Cancer Research. 67(9). 4034–4041. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony J. Perissinotti Breakdown of academic impact, for papers by Mariona Calvo Breakdown of academic impact, for papers by Lihua Xing Breakdown of academic impact, for papers by Marie Simon Breakdown of academic impact, for papers by Christophe Bazin Breakdown of academic impact, for papers by Fukashi Yamamichi Breakdown of academic impact, for papers by K. Ramachandran Breakdown of academic impact, for papers by Canan Vergin Breakdown of academic impact, for papers by Michele W. Sugrue Breakdown of academic impact, for papers by Jennifer Drahos
Rankless by CCL
2026